Live from the NIH registry
Studies recruiting near Indianapolis right now
Top 25 of 913 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Community Health Network, Inc — Indianapolis, Indiana (0.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Handheld Point of Care Electro-Diagnostic Device
Neurologic Findings
N/A
Interventional 30 participants sought
Indiana University Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Indiana University Health Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
Phase 2
Interventional 54 participants sought
Midwest Cornea Associates — Carmel, Indiana (14.0 mi)
· Sponsor: TearSolutions, Inc.
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Indiana University School of Medicine — Indianapolis, Indiana (0.9 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Asthma, Pulmonary Function
N/A
Observational 225 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Oregon Health and Science University
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
Depression, Treatment Resistant
N/A
Interventional 20 participants sought
Goodman Hall Neuroscience Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Primary Mitochondrial Disease
Phase 2
Interventional 180 participants sought
IU Health University Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Pharming Technologies B.V.
Post-Operative Thoracolumosacral Orthosis for PJK
Proximal Junctional Kyphosis, Adult Spinal Deformity Surgery
Phase 4
Interventional 84 participants sought
Indiana Spine Group — Carmel, Indiana (14.0 mi)
· Sponsor: Hospital for Special Surgery, New York
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute
Phase 4
Interventional 100 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: SWOG Cancer Research Network
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
Eskenazi Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Phase 3
Interventional 160 participants sought
The Indiana Clinical Trials Center, PC — Plainfield, Indiana (14.4 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Indianapolis, Indiana (0.9 mi)
· Sponsor: AstraZeneca
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Delricht Research - Better Life Direct Primary Care — Indianapolis, Indiana (0.9 mi)
· Sponsor: Crystalys Therapeutics
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Krannert Institute of Cardiology — Indianapolis, Indiana (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Riley Hospital For Children - PIN — Indianapolis, Indiana (0.9 mi)
· Sponsor: Takeda
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Yale University
Effect of the HCC Liver-Link Intervention
HCC, Racial Disparities
N/A
Interventional 40 participants sought
Indiana University School of Medicine — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 8142 — Indianapolis, Indiana (0.9 mi)
· Sponsor: Galderma R&D